Back to results
US 2010/0168050 A1Published application
Compounds having antiangiogenic activity
AssigneeMedestea Internazionale S.R.L.
InventorMaria Elena FERRERO
Life of this patent
Estimating the term…
Abstract
The use of o-ATP as a pharmacological agent useful for the treatment of diseases in whose onset or progression angiogenesis is involved.
Claims5
A method for treating a tumor disease selected from lymphoma and leukemia in a subject in need thereof, said method comprising administering to said subject an effective amount of adenosine-5′-triphosphate-2′,3′-dialdehyde (oATP).
A method for inhibiting vascular endothelial growth factor (VEGF)-induced cell proliferation of endothelial cells, comprising:
- administering to said endothelial cells an effective amount of adenosine-5′-triphosphate-2′,3′-dialdehyde (oATP).
Dependencies are inferred from the claim text.